Dutagro Soft Capsules 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this drug is 1 capsule (0.5mg) once daily. Since exposure to the capsule contents may cause irritation of the oropharyngeal mucosa, swallow this drug whole without chewing or splitting it. This drug may be taken regardless of meals. No dose adjustment of this drug is necessary in patients with renal impairment or elderly patients. Since there are no data on administration of this drug to patients with hepatic impairment, the recommended dose in these patients has not been established.

This drug can be absorbed through the skin, so women who are pregnant or may become pregnant should not handle this medication directly. If a capsule breaks and the medication comes into contact with the skin, wash it off immediately with clean water and soap. This drug is not to be used by children under 18 years of age, and care should be taken to prevent children from coming into contact with the medication. Women, children under 18 years, and individuals allergic to this drug or similar components should not take this medication. Adult males planning to conceive should take this medication carefully under medical advice, as it may affect reproductive ability. Patients with urinary issues or liver dysfunction should be more cautious when using this drug, and a doctor may need to observe their condition closely. Additionally, patients on strong CYP3A4 inhibitors should exercise caution when using this drug, as the drug concentration could change when combined with certain medications. During treatment, side effects related to sexual function such as erectile dysfunction, decreased libido, ejaculatory disorders, and gynecomastia may occur, which can persist even after discontinuation. The prostate-specific antigen (PSA) levels may decrease during blood tests, so new criteria should be set for interpreting PSA levels after this medication has been taken. This drug may increase the risk of prostate cancer, making it important for patients to undergo regular checks and examinations with their doctors. It is advised to avoid blood donation during and for at least 6 months after taking this medication to prevent its transfer to pregnant women. There is no specific antidote for overdose, thus appropriate treatment should be provided according to symptoms, and extended observation may be necessary due to the drug's long half-life. This medication should be stored out of reach of children, and kept in its original container to prevent quality degradation and misuse. It is known that this drug does not affect driving or machine operation abilities, but individual responses may vary, so caution is warranted. If any abnormal symptoms occur during or after taking this medication, immediate consultation with a medical professional is required.

• Erectile dysfunction
• reduced libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is advisable to keep it at a cool temperature below 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer duration.

Appearance

A yellowish transparent oval soft capsule containing a colorless transparent liquid.

Package unit

30 capsules (15 capsules/PTPX2)